Patient preferences of decision-making in the context of genetic testing for breast cancer risk
Almut W Helmes1, Deborah J Bowen, Jürgen Bengel
1Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, MP900, Seattle, WA 98109, USA.
Purpose:
We conducted a study on women's preferred physician involvement in the decision to obtain genetic testing for breast cancer risk.
Methods:
Women from a primary care physician network completed a telephone survey and a written baseline questionnaire.
Results:
The majority preferred to make up their own minds. Predictors of leaving the decision to providers were less education, less knowledge, and higher external health locus of control. Trust in one's physician mediated the effect of health locus of control on decision method.
Conclusion:
Physicians will face requests from low-risk women and will need effective communication skills to inform women about the test.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Ethical Issues
Ethical Concerns in Healthcare:
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

